Iqstel Financials
This page shows Iqstel (IQST) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Iqstel has an operating margin of -0.3%, meaning the company retains $-0 of operating profit per $100 of revenue. This below-average margin results in a low score of 22/100, suggesting thin profitability after operating expenses. This is down from -0.2% the prior year.
Iqstel's revenue surged 96.0% year-over-year to $283.2M, reflecting rapid business expansion. This strong growth earns a score of 100/100.
Iqstel carries a low D/E ratio of 0.21, meaning only $0.21 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 98/100, indicating a strong balance sheet with room for future borrowing.
Iqstel's current ratio of 0.99 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 15/100, which could limit financial flexibility.
While Iqstel generated -$2.9M in operating cash flow, capex of $152K consumed most of it, leaving -$3.1M in free cash flow. This results in a low score of 22/100, reflecting heavy capital investment rather than weak cash generation.
Iqstel generates a -50.3% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from -9.5% the prior year.
Iqstel passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Iqstel generates $0.49 in operating cash flow (-$2.9M OCF vs -$6.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
Iqstel generated $283.2M in revenue in fiscal year 2024. This represents an increase of 96.0% from the prior year.
Iqstel's EBITDA was -$335K in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 79.1% from the prior year.
Iqstel reported -$6.0M in net income in fiscal year 2024. This represents a decrease of 685.0% from the prior year.
Iqstel earned $-0.04 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 300.0% from the prior year.
Cash & Balance Sheet
Iqstel generated -$3.1M in free cash flow in fiscal year 2024, representing cash available after capex. This represents a decrease of 80.9% from the prior year.
Iqstel held $2.5M in cash against $2.5M in long-term debt as of fiscal year 2024.
Iqstel had 3M shares outstanding in fiscal year 2024. This represents a decrease of 98.5% from the prior year.
Margins & Returns
Iqstel's gross margin was 2.9% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 0.3 percentage points from the prior year.
Iqstel's operating margin was -0.3% in fiscal year 2024, reflecting core business profitability. This is down 0.1 percentage points from the prior year.
Iqstel's net profit margin was -2.1% in fiscal year 2024, showing the share of revenue converted to profit. This is down 1.6 percentage points from the prior year.
Iqstel's ROE was -50.3% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 40.9 percentage points from the prior year.
Capital Allocation
Iqstel invested $152K in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 31.1% from the prior year.
IQST Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $102.9M+42.5% | $72.2M+25.2% | $57.6M-41.7% | $98.9M+82.3% | $54.2M-31.0% | $78.6M+52.9% | $51.4M+8.8% | $47.3M |
| Cost of Revenue | $100.1M+42.4% | $70.3M+26.2% | $55.7M-42.1% | $96.2M+84.2% | $52.2M-31.7% | $76.5M+52.8% | $50.0M+9.7% | $45.6M |
| Gross Profit | $2.7M+46.4% | $1.9M-3.3% | $1.9M-28.6% | $2.7M+34.1% | $2.0M-6.6% | $2.2M+56.9% | $1.4M-16.0% | $1.6M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $3.3M+30.5% | $2.5M-0.5% | $2.5M-14.2% | $3.0M+42.6% | $2.1M-17.1% | $2.5M+60.4% | $1.6M+7.1% | $1.5M |
| Operating Income | -$559K+14.8% | -$656K-8.6% | -$604K-139.8% | -$252K-345.5% | -$57K+83.5% | -$342K-86.5% | -$183K-199.7% | $184K |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | $72K-21.6% | $92K+345.7% | $21K | N/A | $70K+6.6% | $65K | N/A | N/A |
| Net Income | -$2.3M+1.0% | -$2.3M-105.2% | -$1.1M+57.2% | -$2.7M-246.0% | -$773K+60.6% | -$2.0M-238.5% | -$580K-18.7% | -$489K |
| EPS (Diluted) | $-0.68+17.1% | $-0.82 | $-0.44 | N/A | $-0.40+55.6% | $-0.90-143.2% | $-0.37 | N/A |
IQST Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $46.9M-8.8% | $51.4M+22.3% | $42.0M-46.8% | $79.0M+143.6% | $32.4M+8.2% | $30.0M+35.6% | $22.1M-0.2% | $22.2M |
| Current Assets | $29.8M-16.1% | $35.6M+36.5% | $26.0M-58.7% | $63.0M+220.4% | $19.7M+14.2% | $17.2M+10.2% | $15.6M-0.6% | $15.7M |
| Cash & Equivalents | $2.3M+10.8% | $2.0M+87.9% | $1.1M-56.8% | $2.5M+18.1% | $2.1M+166.6% | $797K-70.8% | $2.7M+100.0% | $1.4M |
| Inventory | $31K0.0% | $31K0.0% | $31K0.0% | $31K0.0% | $31K+13.8% | $27K0.0% | $27K-0.7% | $27K |
| Accounts Receivable | $24.0M-21.7% | $30.6M+39.4% | $22.0M-61.6% | $57.2M+281.5% | $15.0M+8.8% | $13.8M+52.9% | $9.0M-28.2% | $12.5M |
| Goodwill | $8.0M+17.9% | $6.8M0.0% | $6.8M0.0% | $6.8M-36.8% | $10.7M0.0% | $10.7M+106.4% | $5.2M0.0% | $5.2M |
| Total Liabilities | $29.0M-21.8% | $37.1M+21.8% | $30.5M-54.6% | $67.1M+175.6% | $24.3M+8.6% | $22.4M+63.1% | $13.7M-2.6% | $14.1M |
| Current Liabilities | $28.7M-22.0% | $36.8M+21.7% | $30.3M-52.6% | $63.8M+165.2% | $24.1M+8.4% | $22.2M+64.6% | $13.5M-2.6% | $13.8M |
| Long-Term Debt | $34K-99.2% | $4.5M+26.0% | $3.5M+44.0% | $2.5M-24.0% | $3.2M+27.0% | $2.5M+2720.9% | $90K-9.0% | $99K |
| Total Equity | $17.9M+25.0% | $14.3M+23.6% | $11.6M-2.9% | $11.9M+47.1% | $8.1M+6.8% | $7.6M-9.6% | $8.4M+4.1% | $8.0M |
| Retained Earnings | -$38.9M-7.0% | -$36.4M-7.3% | -$33.9M-3.8% | -$32.7M-9.6% | -$29.8M-3.2% | -$28.9M-7.5% | -$26.9M-3.1% | -$26.1M |
IQST Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$953K-469.8% | $258K+113.5% | -$1.9M-372.4% | -$404K-164.6% | $625K+123.9% | -$2.6M-387.0% | -$537K+48.8% | -$1.0M |
| Capital Expenditures | $16K-64.8% | $46K-6.5% | $49K+179.4% | $18K-42.4% | $31K-4.0% | $32K-55.6% | $72K+29.5% | $55K |
| Free Cash Flow | -$969K-557.9% | $212K+110.8% | -$2.0M-364.4% | -$421K-170.9% | $594K+122.5% | -$2.6M-334.9% | -$609K+44.9% | -$1.1M |
| Investing Cash Flow | -$46K+60.5% | -$115K-96.4% | -$59K+72.4% | -$213K+7.6% | -$230K+79.0% | -$1.1M+32.4% | -$1.6M-20302.8% | $8K |
| Financing Cash Flow | $1.2M+50.4% | $811K+50.0% | $540K-46.0% | $1.0M+7.3% | $933K-47.7% | $1.8M-49.4% | $3.5M+829.0% | $379K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
IQST Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 2.7%+0.1pp | 2.6%-0.8pp | 3.4%+0.6pp | 2.7%-1.0pp | 3.7%+1.0pp | 2.8%+0.1pp | 2.7%-0.8pp | 3.5% |
| Operating Margin | -0.5%+0.4pp | -0.9%+0.1pp | -1.1%-0.8pp | -0.3%-0.1pp | -0.1%+0.3pp | -0.4%-0.1pp | -0.4%-0.8pp | 0.4% |
| Net Margin | -2.3%+1.0pp | -3.3%-1.3pp | -2.0%+0.7pp | -2.7%-1.3pp | -1.4%+1.1pp | -2.5%-1.4pp | -1.1%-0.1pp | -1.0% |
| Return on Equity | -13.0%+3.4pp | -16.4%-6.5pp | -9.9%+12.6pp | -22.5%-12.9pp | -9.6%+16.4pp | -25.9%-19.0pp | -6.9%-0.9pp | -6.1% |
| Return on Assets | -5.0%-0.4pp | -4.6%-1.8pp | -2.7%+0.7pp | -3.4%-1.0pp | -2.4%+4.2pp | -6.6%-3.9pp | -2.6%-0.4pp | -2.2% |
| Current Ratio | 1.04+0.1 | 0.96+0.1 | 0.86-0.1 | 0.99+0.2 | 0.82+0.0 | 0.78-0.4 | 1.16+0.0 | 1.14 |
| Debt-to-Equity | 0.00-0.3 | 0.310.0 | 0.31+0.1 | 0.21-0.2 | 0.40+0.1 | 0.34+0.3 | 0.010.0 | 0.01 |
| FCF Margin | -0.9%-1.2pp | 0.3%+3.7pp | -3.4%-3.0pp | -0.4%-1.5pp | 1.1%+4.5pp | -3.4%-2.2pp | -1.2%+1.2pp | -2.3% |
Note: The current ratio is below 1.0 (0.99), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Iqstel's annual revenue?
Iqstel (IQST) reported $283.2M in total revenue for fiscal year 2024. This represents a 96.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Iqstel's revenue growing?
Iqstel (IQST) revenue grew by 96% year-over-year, from $144.5M to $283.2M in fiscal year 2024.
Is Iqstel profitable?
No, Iqstel (IQST) reported a net income of -$6.0M in fiscal year 2024, with a net profit margin of -2.1%.
What is Iqstel's EBITDA?
Iqstel (IQST) had EBITDA of -$335K in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Iqstel have?
As of fiscal year 2024, Iqstel (IQST) had $2.5M in cash and equivalents against $2.5M in long-term debt.
What is Iqstel's gross margin?
Iqstel (IQST) had a gross margin of 2.9% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is Iqstel's operating margin?
Iqstel (IQST) had an operating margin of -0.3% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Iqstel's net profit margin?
Iqstel (IQST) had a net profit margin of -2.1% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is Iqstel's return on equity (ROE)?
Iqstel (IQST) has a return on equity of -50.3% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is Iqstel's free cash flow?
Iqstel (IQST) generated -$3.1M in free cash flow during fiscal year 2024. This represents a -80.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Iqstel's operating cash flow?
Iqstel (IQST) generated -$2.9M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Iqstel's total assets?
Iqstel (IQST) had $79.0M in total assets as of fiscal year 2024, including both current and long-term assets.
What are Iqstel's capital expenditures?
Iqstel (IQST) invested $152K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
What is Iqstel's current ratio?
Iqstel (IQST) had a current ratio of 0.99 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.
What is Iqstel's debt-to-equity ratio?
Iqstel (IQST) had a debt-to-equity ratio of 0.21 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Iqstel's return on assets (ROA)?
Iqstel (IQST) had a return on assets of -7.6% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Iqstel's cash runway?
Based on fiscal year 2024 data, Iqstel (IQST) had $2.5M in cash against an annual operating cash burn of $2.9M. This gives an estimated cash runway of approximately 10 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Iqstel's Piotroski F-Score?
Iqstel (IQST) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Iqstel's earnings high quality?
Iqstel (IQST) has an earnings quality ratio of 0.49x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Iqstel?
Iqstel (IQST) scores 43 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.